We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

56 hedge funds and large institutions have $211M invested in Avadel Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

717% more call options, than puts

Call options by funds: $29.6M | Put options by funds: $3.62M

300% more funds holding in top 10

Funds holding in top 10: 1 → 4 (+3)

213% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 8

52% more capital invested

Capital invested by funds: $139M → $211M (+$72.5M)

33% more funds holding

Funds holding: 42 → 56 (+14)

22.5% more ownership

Funds ownership: 49.08% → 71.59% (+23%)

53% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 15

Holders
56
Holders Change
+14
Holders Change %
+33.33%
% of All Funds
1.23%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.09%
New
25
Increased
7
Reduced
15
Closed
8
Calls
$29.6M
Puts
$3.62M
Net Calls
+$26M
Net Calls Change
+$23.8M

Top Buyers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
+$33.5M
2
VC
Vivo Capital
California
+$27.5M
3
CAC
Cowen and Company
New York
+$11.7M
4
RI
RTW Investments
New York
+$9.33M
5
ACP
Acuta Capital Partners
California
+$8.06M

Top Sellers

Rank Fund Capital Flow
1
BIP
Brandes Investment Partners
California
-$15.5M
2
BCM
Brown Capital Management
Maryland
-$13.8M
3
GJL
Gendell Jeffrey L
-$4.56M
4
Morgan Stanley
Morgan Stanley
New York
-$4.33M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
26
Aristides Capital
Kentucky
$568K – – –
KP
27
Keel Point
Alabama
$561K +$236K +30,673 +77%
IAM
28
Iridian Asset Management
Connecticut
$481K -$1.92M -249,869 -80%
CIP
29
Chartwell Investment Partners
Pennsylvania
$437K +$423K +55,065 New
Daiwa Securities Group
30
Daiwa Securities Group
Japan
$366K +$354K +46,100 New
Bank of Montreal
31
Bank of Montreal
Ontario, Canada
$286K +$301K +39,200 +13,067%
Wolverine Trading
32
Wolverine Trading
Illinois
$269K +$237K +30,861 New
IAMOG
33
Investors Asset Management of Georgia
Georgia
$259K -$26.9K -3,500 -10%
EVM
34
Eaton Vance Management
Massachusetts
$255K – – –
Geode Capital Management
35
Geode Capital Management
Massachusetts
$207K -$154K -20,107 -44%
JP Morgan Chase
36
JP Morgan Chase
New York
$180K – – –
Citadel Advisors
37
Citadel Advisors
Florida
$153K -$907K -118,144 -86%
CLOS
38
Compagnie Lombard Odier SCmA
Switzerland
$151K – – –
William Blair & Company
39
William Blair & Company
Illinois
$135K +$131K +17,000 New
CSS
40
Cubist Systematic Strategies
Connecticut
$122K +$118K +15,326 New
Arrowstreet Capital
41
Arrowstreet Capital
Massachusetts
$120K -$668K -87,006 -85%
Northern Trust
42
Northern Trust
Illinois
$118K -$5.31K -691 -4%
Barclays
43
Barclays
United Kingdom
$111K +$108K +14,049 New
Qube Research & Technologies (QRT)
44
Qube Research & Technologies (QRT)
United Kingdom
$88K +$85.2K +11,094 New
PA
45
Perceptive Advisors
New York
$76K – – –
SPIA
46
Steward Partners Investment Advisory
New York
$48K +$13.4K +1,750 +41%
CHA
47
Carmichael Hill & Associates
Maryland
$32K – – –
LFG
48
Larson Financial Group
Missouri
$32K – – –
UBS Group
49
UBS Group
Switzerland
$26K -$30.7K -3,995 -55%
Bank of America
50
Bank of America
North Carolina
$24K +$23K +3,000 New
1
2
3

AVDL Hedge Fund Activity: Q1 2020 in Review

56 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q1 2020, worth a combined $211M — up 52% from $139M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new AVDL positions and 8 closed out — a net gain of 17 holders — while 7 added to existing stakes and 15 trimmed.

The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $33.5M. The largest seller was Brandes Investment Partners, cutting an estimated $15.5M.

  • 56 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q1 2020, up from 42 in Q4 2019.
  • Funds reported $211M of Avadel Pharmaceuticals stock for Q1 2020, up 52% quarter-over-quarter.
  • 25 funds opened new Avadel Pharmaceuticals positions in Q1 2020 and 8 closed out, a net change of +17 holders.
  • The largest Avadel Pharmaceuticals buyer in Q1 2020 was Avoro Capital Advisors, an estimated $33.5M added.
  • The largest Avadel Pharmaceuticals seller in Q1 2020 was Brandes Investment Partners, an estimated $15.5M sold.

Based on aggregated 13F filings for Q1 2020.